Company: AOSL
Filing Date: 2025-09-18
Form Type: DEF 14A
Source: 0001387467-25-000054
Chunk: 20

Company: ALPHA & OMEGA SEMICONDUCTOR Ltd
Filing Date: 2025-09-18
Form: DEF 14A
Chunk 20
---
 aggregate of (i) the total number of meetings of the Board during the period for which he or she has been a director and (ii) the total number of meetings held by all committees of the Board on which the director served during fiscal year 2025. All of our Board members attended our 2024 annual general meeting of shareholders.

#### Committees of the Board
We have three standing committees: an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee. We believe that the composition of these committees meets the criteria for independence, and the functioning of these committees complies with, the applicable requirements, of the Sarbanes-Oxley Act of 2002, as amended, the current rules of the NASDAQ Global Select Market and applicable SEC rules and regulations. The written charters for our Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee are available at the Investor Relations section of our website at http://investor.aosmd.com/ . The contents of this website are not a part of the Proxy Statement. In addition, the Board may delegate certain authorities and powers to a committee of the Board established from time to time in accordance with the Bye-laws of the Company and applicable laws.

Each committee has the composition and responsibilities described below:

#### Audit Committee
Our Audit Committee currently consists of Claudia Chen, Michael L. Pfeiffer and Michael J. Salameh. The Audit Committee is chaired by Ms. Claudia Chen. Our Board of Directors has determined that Ms. Claudia Chen is an Audit Committee financial expert, as defined by the rules and regulations promulgated by the SEC. Our Audit Committee held six meetings during fiscal year 2025. The Audit Committee’s responsibilities include:

• assisting our Board in its oversight of the integrity of our financial statements, risk management and internal control over financial reporting;

• retaining and setting compensation of our independent registered public accounting firm (“independent auditors”), evaluating and monitoring its performance, and as appropriate, discharging our independent auditors;

• reviewing and approving all audit and non-audit services of our independent auditors;

• reviewing and discussing with management and our independent auditors our financial statements included in public filings;

<div align='center'>11</div>

• discussing with our independent auditors significant financial reporting issues in connection with the preparation of our financial statements;

• resolving any disagreements between management and our independent auditors regarding financial reporting;

• overseeing our disclosure controls and procedures; and

• reviewing and approving related party transactions.

#### Compensation